SCHEMBL23334533

SCHEMBL23334533

Cc1sc2c(c1CN1CCN3C(=O)CNC(=O)C3C1)=CCCC=2

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23334088 0.84 — —
SCHEMBL23334399 0.82 MEN1 (0.36) —
SCHEMBL23334536 0.81 — —
SCHEMBL24938970 0.80 CYP1A2 (0.38) SMN1; SMN2
SCHEMBL23334414 0.74 — —
SCHEMBL23302562 0.72 NPY1R (0.35) —
SCHEMBL29695401 0.72 NPY1R (0.35) —
SCHEMBL23303909 0.72 NPY1R (0.35) —
SCHEMBL24152329 0.72 GSK3B (0.50) SMN1; SMN2
SCHEMBL23967364 0.72 ALDH1A1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086038-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME 홀로스메딕 주식회사 2021-05-06 — — WO disclosed
Send feedback